oric-114
oric-114: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Oric Pharmaceuticals, Inc. (ORIC) | Phase 1/Phase 2 |
Clinical Trials (1)
An Open-Label, Phase 1/2 Study of ORIC-114 as a Single Agent or in Combination With Chemotherapy, in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
Frequently asked questions
Who is developing oric-114?
oric-114 is being developed by Oric Pharmaceuticals, Inc..
How many clinical trials involve oric-114?
BioSniper tracks 1 clinical trial involving oric-114.
Get deeper analysis on oric-114
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis